ropinirole (Requip, Requip XL)
GENERIC NAME: ropinorole hydrochloride
BRAND NAME: Requip, Requip XL
DRUG CLASS AND MECHANISM: Ropinorole is an anti-Parkinson's medication. Ropinorole works by binding to dopamine receptors in the brain. Ropinorole stimulates the dopamine receptors and improves symptoms of Parkinson's disease. The FDA approved ropinirole in September 1997. It is also a treatment for Restless legs syndrome (RLS ).
GENERIC AVAILABLE: Yes
PREPARATIONS: Tablets (immediate release): 0.25, 0.5, 1, 2, 3, 4, 5 mg. Tablets (extended-release): 2, 4, 6, 8, 12 mg
STORAGE Store ropinorole immediate-release and extended-release tablets between temperatures 15 C and 30 C (59 F and 86 F).
PRESCRIBED FOR: Ropinorole is used for the treatment of signs and symptoms of Parkinson's disease and moderate-to-severe restless leg syndrome (RLS).
Immediate-release tablets: Take 0.25 mg by mouth 3 times a day for week 1, then increase weekly by 0.25 mg 3 times a day if needed. After week 4 doses may be increased by 1.5 mg/day on weekly basis up to a dose of 9 mg/day. If still needed, may increase doses by 3 mg/day on a weekly basis to a total dose of 24 mg/day.
Extended-release tablets: Take 2 mg by mouth once daily for 1 to 2 weeks. Doses can be increased by 2 mg/day at intervals longer than week. Not to exceed 24 mg/day.
Restless Leg Syndrome (RLS)
Medically Reviewed by a Doctor on 10/3/2014
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Need help identifying pills and medications?
Back to Medications Index